Teleflex (NYSE:TFX) Stock Rating Upgraded by Wall Street Zen

Key Points

• Wall Street Zen upgraded Teleflex from a "sell" to a "hold", and the shares carry a MarketBeat consensus rating of Hold with an average analyst target price of $138.50 (3 Buy, 5 Hold, 2 Sell).
• Teleflex posted a significant quarterly earnings miss — $1.93 EPS vs. $3.73 expected and $569M revenue vs. $912.6M expected — with revenue down 28.5% year-over-year and a negative net margin of 30.56%.
• The company set FY 2026 guidance at $6.25–$6.55 EPS (analysts average 6.77), and the stock trades near $136.86 with a $6.06B market cap and a 52‑week range of $100.18–$139.67.

Teleflex (NYSE:TFX - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "sell" rating to a "hold" rating in a research report issued on Saturday.

A number of other research analysts have also issued reports on TFX. Wells Fargo & Company lifted their target price on Teleflex from $116.00 to $130.00 and gave the company an "equal weight" rating in a report on Friday, February 27th. Needham & Company LLC lifted their target price on Teleflex from $138.00 to $147.00 and gave the company a "buy" rating in a report on Thursday, February 26th. Weiss Ratings reiterated a "sell (d)" rating on shares of Teleflex in a report on Friday, March 27th. Royal Bank Of Canada reiterated a "sector perform" rating on shares of Teleflex in a report on Tuesday, April 14th. Finally, Raymond James Financial upgraded Teleflex from a "market perform" rating to an "outperform" rating and set a $128.00 target price for the company in a report on Friday, March 27th. Three analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $138.50.

Teleflex Trading Up 0.2%

TFX opened at $136.86 on Friday. Teleflex has a 52 week low of $100.18 and a 52 week high of $139.67. The business has a fifty day simple moving average of $116.87 and a 200-day simple moving average of $116.59. The firm has a market cap of $6.06 billion, a P/E ratio of -6.66, a P/E/G ratio of 0.98 and a beta of 0.84. The company has a quick ratio of 2.01, a current ratio of 2.54 and a debt-to-equity ratio of 0.81.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, February 26th. The medical technology company reported $1.93 EPS for the quarter, missing the consensus estimate of $3.73 by ($1.80). The firm had revenue of $569.00 million for the quarter, compared to analysts' expectations of $912.57 million. Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.The company's quarterly revenue was down 28.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.89 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, equities analysts expect that Teleflex will post 6.77 earnings per share for the current year.

Institutional Trading of Teleflex

A number of institutional investors have recently bought and sold shares of TFX. MassMutual Private Wealth & Trust FSB increased its position in shares of Teleflex by 57.9% during the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company's stock worth $26,000 after purchasing an additional 77 shares in the last quarter. Banque Cantonale Vaudoise increased its position in shares of Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company's stock worth $31,000 after purchasing an additional 113 shares in the last quarter. Hantz Financial Services Inc. increased its position in shares of Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company's stock worth $34,000 after purchasing an additional 199 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Teleflex during the third quarter worth about $35,000. Finally, V Square Quantitative Management LLC acquired a new stake in shares of Teleflex during the fourth quarter worth about $37,000. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.